Insider Sell: CFO Richard Riggsbee Sells 30,000 Shares of Myriad Genetics Inc
On November 1, 2023, Richard Riggsbee, the Chief Financial Officer (CFO) of Myriad Genetics Inc (NASDAQ:MYGN), sold 30,000 shares of the company.
Stay updated with breaking news from Genetics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On November 1, 2023, Richard Riggsbee, the Chief Financial Officer (CFO) of Myriad Genetics Inc (NASDAQ:MYGN), sold 30,000 shares of the company.
Myriad Genetics (NASDAQ:MYGN – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday. Several other analysts also recently issued reports on MYGN. JPMorgan Chase & Co. decreased their target price on Myriad Genetics from $18.00 to $17.00 and […]
The global market for Autoimmune Disease Testing is expected to grow from US$ 6.07 billion in 2023 to $15.75 billion by 2033. According to FMI, global demand for autoimmune disease testing could grow at a 10% CAGR from 2023 to 2033.The rising incidence of autoimmune disorders, such as rheumatoid arthritis, lupus, an...
According to marketresearch.biz, advancements in genomic studies, driven by technologies like next-generation sequencing (NGS) and microarrays, are...
31.10.2023 - SALT LAKE CITY, Oct. 31, 2023 (GLOBE NEWSWIRE) - Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will hold its third quarter earnings conference call on Monday, November 6, 2023 at 4:30 p.m. EDT. The ...